期刊文献+

自体外周血造血干细胞移植治疗非霍奇金淋巴瘤56例临床分析 被引量:2

Autologous peripheral blood hematopoietic stem cell transplantation in 56 patients with non-hodgkin's lymphoma
下载PDF
导出
摘要 目的:探讨自体外周血造血干细胞移植(autologous peripheral blood stem cell transplantation,APBSCT)治疗非霍奇金淋巴瘤(non-Hodgkin’s lymphoma,NHL)的临床疗效。方法:回顾性分析2009年2月至2013年10月在我院行APBSCT的NHL患者56例,其中男37例,女19例,中位年龄44岁(16~69)岁,缓解病例46例,部分缓解7例,复发难治3例。结果:56例移植患者中55例获造血重建,1例未造血重建。中性粒细胞绝对值〉0.5×109个/L的中位时间9.5 d(7~18 d)、血小板计数〉20×109个/L的中位时间11.5 d(6~24 d)。24例患者于粒细胞缺乏期时出现发热,5例出现轻中度腹泻,1例出现轻度肝功能损害,1例出现带状疱疹。所有患者随访截止于2014年4月1日,中位随访时间20.25月(3.0~60.5月)。45例存活(其中5例带病生存),10例复发,11例死亡(其中5例死于复发)。复发率为17.9%,总生存率(overall survival,OS)、无病生存率(disease free survival,DFS)分别为80.4%、71.4%。结论:APBSCT是治疗NHL的有效手段,造血重建快,并发症少。 Objective:To study the clinical efficacy of autologous peripheral blood hematopoietic stem cell transplantation(APBSCT)in the treatment of non-Hodgkin’s lymphoma(NHL). Methods:A total of 56 patients who underwent APBSCT from February 2009 toOctober 2013 in the hospital were enrolled in the study. There were 37 males and 19 females with a median age of 44 years(16-69 years);46 cases were in remission,7 cases in partial remission and 3 cases in relapsed or refractory. Results:Among56 patients treated by APBSCT,55 patients obtained hematopoietic reconstitution. The median time for neutrophils recovery(〉0.5×109/L)was 9.5(7-18)d and platelet recovery(〉20×109/L) was 11.5(6-24) d. Twenty-four patients experienced fever during granulocyte lack phase,5 patients experiencedmild-to-moderate diarrhea,one patient had mild liver function damage and one patient had herpes zoster. All patients were followed up till the 1st April,2014,and the median follow-up time was 20.25(3-60.5)months. Forty-five cases survived(5 cases alive with disease);10 cases relapsed;11 cases died(5 cases died of recurrence). The recurrence rate was 17.9%. Overall survival and diseasefree survival were 80.4% and 71.4% respectively. Conclusion:With the advantages of quicker hematopoietic reconstruction and fewer non-Hodgkin’s lymphoma,APBSCT is effective in the treatment of NHL.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2015年第1期154-158,共5页 Journal of Chongqing Medical University
基金 国家自然科学基金资助项目(编号:81250034) 重庆市卫生局资助项目(编号:2013-2-023) 重庆市教委资助项目(编号:2013)
关键词 造血干细胞移植 自体 非霍奇金淋巴瘤 hematopoietic stem cell transplantation autologous non-Hodgkin’s lymphoma
  • 相关文献

参考文献7

二级参考文献71

  • 1刘华,王蔚,陈俊民,郑垂志.乙型肝炎病毒感染与恶性淋巴瘤关系的探讨[J].白血病.淋巴瘤,2005,14(1):27-28. 被引量:21
  • 2付杰,李晓林,薛燕,杨扬,王洋,李晟,渠慎英,惠红侠.自体造血干细胞移植治疗恶性淋巴瘤[J].白血病.淋巴瘤,2005,14(6):379-380. 被引量:7
  • 3张明智,吴广银,孙振昌,何振,李鑫,耿丽.NHL患者HBV感染分析[J].肿瘤基础与临床,2006,19(6):467-468. 被引量:8
  • 4秦鑫添,吕跃,陈晓勤,徐海鹏,樊慧杰.HBV感染与非霍奇金淋巴瘤的关系[J].癌症,2007,26(3):294-297. 被引量:30
  • 5张之南.血液病疗效及诊断标准[M].北京:北京科学出版社,1998:210-215,347-348.
  • 6Segal BH,Baden LR,Brown AE,et al.NCCN Clinical Practice Guidelines in Oncology.Prevention and Treatment of Cancer-related Infections.NCCN,V.2,2009.
  • 7Freifeld A,Boeckh M,Bow EJ,et al.Clinical Practice Guideline for the Use of Antimicrobial agents in Neutropenic Patients with Cancer.Infectious Diseases Society of America(IDSA),2007.
  • 8Tenover FC, Mohanned MJ, Gorton TS, et al. Detection and reporting of organisms producing extended spectrum betalactamases: survey of laboratories in Connecticut. J Clin Microbiol, 1999,37 (12) : 4065-4070.
  • 9Wiener J, Quinn JP, Bradford PA, et al. Multiple antibiotics-resistant Klebsiella and Escherichia coli in nursing homes.JAMA, 1999,281(6) : 517-523.
  • 10Wong-Beringer A, Hinder J, Loeloff M, et al. Moleculer correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime. Ciln Infect Dis, 2002,34 (2) : 135-146.

共引文献52

同被引文献23

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部